EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
151 hedge funds and large institutions have $659M invested in Eagle Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 62 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
31% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 62
Holders
151
Holding in Top 10
3
Calls
$1.63M
Puts
–
Top Buyers
| 1 | +$9.22M | |
| 2 | +$5.23M | |
| 3 | +$5.02M | |
| 4 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
+$3.01M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.4M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$7.37M | |
| 3 | -$5.06M | |
| 4 |
Millennium Management
New York
|
-$2.97M |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$2.44M |